Chongqing Zhongxiang Trading Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chongqing Zhongxiang Trading Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ZGZXSEXHZ. The owner is based in Chongqing.

No. 3, Longhai Avenue, Banan District

30-6, Building 12

Chongqing 400000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZGZXSEXHZ
ZGZXSEXHZ
Registered 2024

Trademark Classifications

Chongqing Zhongxiang Trading Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Chongqing Zhongxiang Trading Co., Ltd. have?

Chongqing Zhongxiang Trading Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chongqing Zhongxiang Trading Co., Ltd. file in?

Chongqing Zhongxiang Trading Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Chongqing Zhongxiang Trading Co., Ltd.'s most well-known trademarks?

Chongqing Zhongxiang Trading Co., Ltd.'s registered trademark portfolio includes well-known marks such as ZGZXSEXHZ. These are among 1 currently registered trademark in the portfolio.

What is Chongqing Zhongxiang Trading Co., Ltd.'s trademark registration success rate?

Chongqing Zhongxiang Trading Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.